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Abstract
Background: The Centers for Medicare and Medicaid Services (CMS) has implemented the CMS-Hierarchical
Condition Category (CMS-HCC) model to risk adjust Medicare capitation payments. This study intends to assess the
performance of the CMS-HCC risk adjustment method and to compare it to the Charlson and Elixhauser
comorbidity measures in predicting in-hospital and six-month mortality in Medicare beneficiaries.
Methods: The study used the 2005-2006 Chronic Condition Data Warehouse (CCW) 5% Medicare files. The primary
study sample included all community-dwelling fee-for-service Medicare beneficiaries with a hospital admission
between January 1
st, 2006 and June 30
th, 2006. Additionally, four disease-specific samples consisting of subgroups
of patients with principal diagnoses of congestive heart failure (CHF), stroke, diabetes mellitus (DM), and acute
myocardial infarction (AMI) were also selected. Four analytic files were generated for each sample by extracting
inpatient and/or outpatient claims for each patient. Logistic regressions were used to compare the methods.
Model performance was assessed using the c-statistic, the Akaike’s information criterion (AIC), the Bayesian
information criterion (BIC) and their 95% confidence intervals estimated using bootstrapping.
Results: The CMS-HCC had statistically significant higher c-statistic and lower AIC and BIC values than the Charlson
and Elixhauser methods in predicting in-hospital and six-month mortality across all samples in analytic files that
included claims from the index hospitalization. Exclusion of claims for the index hospitalization generally led to
drops in model performance across all methods with the highest drops for the CMS-HCC method. However, the
CMS-HCC still performed as well or better than the other two methods.
Conclusions: The CMS-HCC method demonstrated better performance relative to the Charlson and Elixhauser
methods in predicting in-hospital and six-month mortality. The CMS-HCC model is preferred over the Charlson and
Elixhauser methods if information about the patient’s diagnoses prior to the index hospitalization is available and
used to code the risk adjusters. However, caution should be exercised in studies evaluating inpatient processes of
care and where data on pre-index admission diagnoses are unavailable.
Background
Randomized controlled trials are not practically feasible
in all situations given time, costs and/or ethical consid-
erations. Observational studies using administrative
claims data are being increasingly used in an attempt to
address gaps in evidence where randomized trials are
unavailable. However, the validity of the results from
such secondary database analyses often face the threat
of potential confounding associated with the differences
in the baseline health status between patients. Risk
adjustment methods are commonly used to address this
threat with the most frequently used methods being the
Charlson [1] and the Elixhauser [2] methods. These
methods were developed for research purposes and
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any medium, provided the original work is properly cited.utilize the International Classification of Diseases, Ninth
Revision, Clinical Modification (ICD-9-CM) codes to
determine a set of comorbidities shown to be predictive
of outcomes including mortality.
The Centers for Medicare and Medicaid Services
(CMS) has implemented a risk adjustment system, the
CMS hierarchical condition categories (CMS-HCC)
model to adjust capitation payments made to private
plans in Medicare [3]. It “uses demographics and a diag-
nosis-based medical profile captured during all clinician
encounters–both inpatient and outpatient–to produce a
health-based measure of future medical need”[3,4]. In
addition to generating a series of condition categories, it
generates a summary risk score for each patient.
Because it was originally developed for payment pur-
poses, the CMS-HCC has been shown to be a significant
predictor of health care costs, but has yet to be tested
with health outcomes. Current methods of risk adjust-
ment may be improved with the additional information
retrieved by the CMS-HCC.
This study attempts to assess the performance of the
CMS-HCC as a risk adjustment method in predicting
mortality and to compare it with the Charlson and Elix-
hauser methods. We compare these three risk adjust-
ment methods among all Medicare beneficiaries with a
hospital admission and disease-specific samples consist-
ing of patients with principal diagnoses of congestive
heart failure (CHF), stroke, diabetes mellitus (DM), and
acute myocardial infarction (AMI).
Methods
Data source
This study used data from the 2005 and 2006 Chronic
Condition Data Warehouse (CCW) 5% Medicare files.
Specifically, we used personal summary, inpatient, and
outpatient files for a 5 percent random sample of Medi-
care beneficiaries. The inpatient file included one record
per hospitalization summarizing all services rendered to
a beneficiary from the time of hospital admission
through discharge. The outpatient files included claims
submitted by both institutional outpatient providers (e.g.
hospital outpatient departments) and carrier claims sub-
mitted by non-institutional outpatient providers (e.g.
physicians). We also used the personal summary file
which captures demographic, enrollment, and adminis-
trative information on beneficiaries.
Study samples
We evaluated the three risk adjustment methods in five
samples. The primary study sample included all commu-
nity-dwelling fee-for-service Medicare beneficiaries with
a hospital admission between January 1
st, 2006 and June
30
th, 2006. Additionally, four disease-specific samples
consisting of subgroups of patients who had a
hospitalization with a primary diagnosis of (1) stroke
(ICD-9-CM: ‘3623’, ‘430’, ‘431’, ‘433’-’436’); (2) DM
(ICD-9-CM: ‘250’); (3) AMI (ICD-9-CM: ‘410’); or (4)
CHF (ICD-9-CM: ‘4254’, ‘4255’, ‘4257’, ‘4258’, ‘4259’,
‘428’) during the six-month observation period between
January 1
st , 2006 and June 30
th, 2006 were also
selected. We selected the four conditions because they
provide a mix of acute and chronic conditions that are
common reasons for hospital admissions. Approximately
47% of all Medicare patients in the 5% CCW impatient
file were discharged from hospitals during 2006 with at
least one diagnosis of the four conditions. The first hos-
pitalization during the six-month observation period
was identified as the index hospitalization. The admis-
sion date of the index hospitalization was identified as
the index date. Additional inclusion criteria for the
study samples were fee-for-service Medicare Part A and
B coverage for at least 12-month prior to the index
admission and Medicare enrollment up to six months
after the index date or death, whichever came first.
Outcomes
The outcomes of interest were in-hospital all-cause
mortality and six-month all-cause mortality. In-hospital
mortality was defined as death during the index hospita-
lization stay. Six-month mortality was defined as death
within 180 days of the index hospital admission. In-hos-
pital mortality was also counted as part of the six-
month mortality outcome. The vital status and date of
death for each beneficiary was identified using the CCW
personal summary file.
Risk adjustment measures
Charlson Method
The Charlson comorbidity index was originally derived
to classify comorbidities that might alter the risk of
mortality in individuals in longitudinal studies [1]. Nine-
teen comorbidities were identified with a relative risk of
mortality of 1.2 or greater. A weighted index was cre-
ated to take into account the number and seriousness of
the comorbidities. There have been several adaptations
of the Charlson index for use with administrative data.
Each adaptation consists of a set of ICD-9-CM diagnosis
codes associated with each of the comorbidities identi-
fied by the Charlson index. The Deyo [5] and Dart-
mouth-Manitoba adaptations [6] are the most common
adaptations. It has been shown that only minor differ-
ences exist between the two methods and that they
identify comparable numbers of comorbidities and have
similar predictive power. In our study, the Charlson
comorbidity measures were derived from the Dart-
mouth-Manitoba adaptation of the original Charlson
method which includes broader definitions for periph-
eral vascular disease, complications of diabetes, and
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in this adaptation of the Charlson method [6].
Elixhauser Method
The Elixhauser comorbidities method derives a compre-
hensive set of 30 comorbidities which were associated
with increases in hospital length of stay, hospital
charges, and in-hospital mortality [2]. The Elixhauser
method extends the Charlson method by including addi-
tional comorbidities that were found to be strongly asso-
ciated with these outcomes. Unlike the CMS-HCC and
Charlson methods, the Elixhauser method does not pro-
vide a summary score. A weighted score was not derived
because results showed that including the individual
comorbidities were found to be more effective. However,
for purposes of comparison with the other two risk-
adjusters, we created a summary score for Elixhauser
method by summing up the total number of Elixhauser
comorbidities.
CMS-HCC
The CMS-HCC model aggregates all ICD-9-CM codes
into 189 condition categories which describe a broad set
of similar diseases organized into organ systems [3].
Condition categories (CCs) are arranged in a hierarchy
among similar diseases based on the severity of the dis-
ease which results in hierarchical condition categories
(HCCs). Diagnoses were excluded if they were not medi-
cally significant, transitory or did not impact costs. A
final count of 70 categories were developed to risk
adjust costs. It then applies previously calibrated weights
to each category to create a single risk score. The
weights for each category were determined based on
coefficients from a multiple regression on Medicare pay-
ments [3]. The traditional CMS-HCC risk adjustment
method includes age, gender and Medicaid eligibility
status for generating the CMS-HCC risk score. To
ensure a fair comparison across the three risk adjust-
ment methods, we removed the influence of these vari-
ables and only included the clinical condition categories
to generate the CMS-HCC risk score. Also health ser-
vices researchers often want to estimate the independent
effects of demographic information (e.g. age, gender and
eligibility status) while adjusting for the clinical disease
burden. Thus, from a practical application standpoint it
is useful to build the CMS-HCC risk score without
patient demographic information.
Analysis
Logistic regressions estimating mortality were used to
compare the three risk adjustment methods, namely the
Charlson, Elixhauser, and CMS-HCC method. A sum-
mary score version and clinical condition indicators ver-
sion was created for each of these risk adjustment
methods, thus resulting in a comparison of six risk-
adjustment approaches. Programs to generate the CMS-
HCC, Elixhauser, and Charlson risk scores were down-
loaded from the websites of CMS [7], Agency for
Healthcare Research and Quality (AHRQ) [8], and Man-
itoba Center for Health Policy, University of Manitoba
[9], respectively.
Traditionally, only inpatient files were used to code
Charlson and Elixhauser comorbidities [1,2,5]. However,
conditions from CMS-HCC were assigned not only
using all diagnoses from inpatient files but also hospital
outpatient and physician claims files [3]. More recently,
outpatient and physician claims have also been used to
code Charlson Comorbidities [10,11]. For a fair compar-
ison of the different methods, we used the same analytic
file to code each of the three risk adjustment methods.
We created four analytic files for the primary sample
and each of the four disease-specific samples (CHF,
stroke, DM, and AMI). The first analytic file (IPindex)
only included claims from the index hospitalization for
each sample. The second file (IPpre12mo+index)
included all inpatient claims in the 12 months prior to
the index hospitalization including those occurring on
the index admission date. The third analytic file (IP
+OPpre12mo+index) included all inpatient and outpati-
ent claims in the 12 months prior to the index hospitali-
zation including those occurring on the index admission
date. The fourth analytic sample (IP+OPpre12mo)
included all inpatient and outpatient claims in the
12 months prior to the index hospitalization excluding
those occurring on the index admission date.
Clinical diagnoses (e.g. comorbidities) under the three
risk adjustment methods were identified using the ICD-
9-CM diagnosis codes on the claims included in each of
the four analytic files for the five samples. Summary
scores and binary indicators of the clinical diagnoses
were created to allow comparison of the six risk adjust-
ment approaches in predicting the two outcomes, in-
hospital mortality and six-month mortality. A total of
240 logistic regression models were estimated [5 sam-
ples*4 analytic files*6 risk adjustments methods (3 sum-
mary score and 3 separate indicators) *2 outcomes].
Each model included variables on the patient’sa g e( a sa
linear and quadratic term) and gender.
Model performance was assessed using the c-statistic,
t h eA k a i k ei n f o r m a t i o nc r i t erion (AIC) [12], and the
Bayesian information criterion (BIC) [13] in predicting
mortality. The c-statistic is a measure of model discrimi-
nation and is equivalent to the area under the receiver
operating characteristics (ROC) curve [14]. The c-statis-
tic value of 0.5 indicates that the model’s performance
of prediction is equal to random chance. The highest
value of c-statistic is 1 which indicates the perfect discri-
mination power of the model. Due to issues of
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secondary measures for additional checks to determine
goodness of fit. The AIC and BIC introduce a penalty
term for additional parameters in the model, thereby
reducing the problems associated with overfitting [15].
The AIC and BIC can be used for model comparison
among a class of parametric models having the same
dependent variable, but with different numbers of inde-
pendent parameters. Within a set of estimated models,
the models with the lowest AIC and BIC values are pre-
ferred. Unlike the F-test or the likelihood ratio test, the
models being compared do not need to be nested [16].
We also computed the 95% confidence intervals for the
c-statistic, AIC, and BIC using bootstrap methods. We
generated 3000 bootstrap replicates of the original data
set using random sampling with replacement. In each
bootstrap sample, we ran all models to generate the
c-statistic, AIC, and BIC.
Results
The primary sample included a total of 170,342
patients with a hospital admission between January 1
st
2006 and June 30
th 2006. The mean age of the sample
was 78 years and 40% were males. The inpatient mor-
tality rate was 3% and six-month mortality rate was
14%. Across the four disease-specific samples a total of
2,339 DM, 9,828 stroke, 5,749 AMI, and 11,287 CHF
patients were included in our study. The mean age of
the patients ranged from 73.3 (DM) to 80.1 years
(CHF) and the percentage of males ranged from 40.2%
(stroke) to 49.6% (DM). Inpatient mortality was the
highest for AMI (8.5%), followed by stroke (5.5%),
CHF (3.6%), and DM (1.7%). Six-month mortality rates
were similar and highest in CHF (23.3%) and AMI
(23.1%) patients followed by stroke (18.1%) and DM
(14.4%) patients.
Table 1 lists the c-statistic values from the logistic
regression models estimating the risk of in-hospital
mortality for patients in each of the five samples. In
models using the summary score for risk adjustment,
the CMS-HCC method achieved statistically significant
higher levels of discrimination relative to the Charlson
and Elixhauser methods for the primary sample and all
four disease samples except for the fourth analytic file
(IP+OPpre12mo) in DM patients. In models using the
individual diagnosis indicators for risk adjustment, con-
vergence was not complete for some models in disease-
specific samples due to complete or quasi-complete
separation [17]. C-statistic values were not available for
these models and are not shown. Among models with
c-statistic values available for all three risk adjusters, the
CMS-HCC indicator models had significantly higher
c-statistic values than the Charlson and Elixhauser indi-
cators models.
Table 2 shows the c-statistic values from the logistic
regression models predicting the risk of six-month mor-
tality. Similar to the findings for in-patient mortality, the
summary score based on the CMS-HCC models had
statistically significant levels of higher discrimination
than the other two summary score based risk adjust-
ment methods among all analytic files and across all
samples. The models with individual diagnosis indicators
converged in all analytic files for all samples except in
two analytic files of the DM sample. Across all disease
samples, the CMS-HCC indicator models had statisti-
cally significant higher c-statistic values than the Charl-
son and Elixhauser methods.
The results for the models predicting risk of in-patient
and six-month mortality showed that the CMS-HCC
method had substantially higher discrimination than the
other two risk adjustment methods when we included
the index admission claim in coding the risk adjusters.
This was done in the first (IPindex), second (IPpre12mo
+ i n d e x )a n dt h i r da n a l y t i c( IP+OPpre12mo+index) files
which contained the index admission. When we only
used the pre-index inpatient and outpatient claims (i.e.
the fourth analytic file: IP+OPpre12mo) to code risk
adjusters, the CMS-HCC generally still had better discri-
mination than the other two methods overall. However,
t h ed i f f e r e n c ew a sm u c hs m a ller. In models including
the individual diagnosis indicators of each risk adjust-
ment method, the Elixhauser method generally outper-
formed the Charlson method in both in-patient
mortality and six-month mortality models with higher
c-statistic values. Because our objective was to compare
the CMS-HCC method to the Elixhauser and Charlson
method, we did not conduct statistical tests to compare
the Elixhauser and the Charlson methods against each
other.
Table 3 highlights the importance of including or
excluding the index date claim in coding diagnoses and
the summary score across the different risk adjustment
approaches by measuring changes in the c-statistic.
After excluding claims on the index date from all inpati-
ent and outpatient claims within 12 months prior to the
index admission, there were generally drops in model
performance in predicting the risk of in-patient and six-
month mortality. However, the drop in performance
varied depending on the sample and risk adjustment
method. The CMS-HCC had statistically significant
drops in the c-statistic. Even though the Charlson and
Elixhauser also experienced drops in performance, the
reductions were smaller. In spite of this, the CMS-HCC
still performed as well or better than the other two
methods when we used only pre-index claims to code
risk adjusters. In the CMS-HCC models, the influence
of including the index date claim had a larger influence
on c-statistic values in models predicting in-patient
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a
Study sample Analytic file used to code risk adjusters
b Summary score Indicators
CMS-HCC Charlson Elixhauser CMS-HCC Charlson Elixhauser
All patients
c (N = 170,342)
1) IPindex 0.853 0.649** 0.632** 0.917 0.68** 0.761**
(0.849,
0.858)
(0.641,
0.656)
(0.624,
0.639)
(0.913,
0.921)
(0.673,
0.688)
(0.755,
0.768)
2) IPpre12mo+index 0.826 0.66** 0.649** 0.904 0.682** 0.751**
(0.821,
0.831)
(0.652,
0.668)
(0.642,
0.657)
(0.901,
0.909)
(0.675,
0.689)
(0.745,
0.758)
3) IP+OPpre12mo +index 0.798 0.669** 0.67** 0.889 0.683** 0.735**
(0.793,
0.803)
(0.661,
0.676)
(0.664,
0.678)
(0.886,
0.894)
(0.676,
0.691)
(0.729,
0.742)
4) IP+OPpre12mo 0.665 0.652** 0.643** 0.693 0.662** 0.675**
(0.658,
0.672)
(0.644,
0.659)
(0.636,
0.651)
(0.688,
0.701)
(0.655, 0.67) (0.669,
0.683)
DM (N = 2,339)
1) IPindex 0.772 0.615** 0.627** NA 0.674 NA
(0.722,
0.853)
(0.546,
0.723)
(0.549,
0.726)
(0.634, 0.79)
2) IPpre12mo+index 0.764 0.664** 0.651** NA NA NA
(0.701,
0.835)
(0.599,
0.753)
(0.574,
0.744)
3) IP+OPpre12mo +index 0.744 0.674** 0.654** NA NA NA
(0.68, 0.816) (0.62, 0.76) (0.596,
0.746)
4) IP+OPpre12mo 0.662 0.69 0.644** NA 0.73 NA
(0.602,
0.751)
(0.618,
0.768)
(0.575,
0.729)
(0.694,
0.814)
Stroke (N = 9,828)
1) IPindex 0.783 0.574** 0.575** NA 0.607 0.672
(0.759,
0.798)
(0.552, 0.6) (0.553,
0.601)
(0.59, 0.636) (0.657,
0.702)
2) IPpre12mo+index 0.749 0.576** 0.581** NA 0.62 0.663
(0.722,
0.764)
(0.554,
0.603)
(0.557,
0.607)
(0.604, 0.65) (0.649,
0.693)
3) IP+OPpre12mo +index 0.72 0.577** 0.591** NA 0.623 0.656
(0.695,
0.736)
(0.555,
0.604)
(0.57, 0.618) (0.609,
0.655)
(0.644,
0.689)
4) IP+OPpre12mo 0.592 0.576** 0.578** 0.676 0.615** 0.614**
(0.57, 0.618) (0.553,
0.602)
(0.557,
0.606)
(0.675,
0.718)
(0.601,
0.647)
(0.607,
0.652)
AMI (N = 5,749)
1) IPindex 0.767 0.621** 0.625** NA 0.646 NA
(0.746,
0.784)
(0.599,
0.648)
(0.601,
0.651)
(0.627,
0.675)
2) IPpre12mo+index 0.743 0.628** 0.628** 0.852 0.647** 0.705**
(0.721,
0.762)
(0.605,
0.655)
(0.606,
0.655)
(0.84, 0.874) (0.63, 0.678) (0.688,
0.731)
3) IP+OPpre12mo +index 0.721 0.63** 0.645** NA 0.647 0.697
(0.7, 0.743) (0.606,
0.656)
(0.622,
0.671)
(0.631, 0.68) (0.685,
0.729)
4) IP+OPpre12mo 0.64 0.629** 0.634** NA 0.648 0.659
(0.617,
0.668)
(0.606,
0.655)
(0.611,
0.661)
(0.632, 0.68) (0.648,
0.696)
CHF(N = 11,287)
1) IPindex 0.738 0.615** 0.609** 0.822 0.652** 0.718**
Li et al. BMC Health Services Research 2010, 10:245
http://www.biomedcentral.com/1472-6963/10/245
Page 5 of 10mortality than in the models predicting six-month mor-
tality. In general, the stroke sample had larger drops in
the c-statistic for the CMS-HCC model than other dis-
ease-specific samples.
The results of the AIC and BIC were consistent with
those based on the c-statistic values (Data not shown.
Results are available from the authors upon request).
Overall, the CMS-HCC models performed better (i.e.
had lower AIC and BIC values) than the Charlson and
Elixhauser models in the analytic files across the five
samples. However, some differences were not statisti-
cally significant. After excluding claims on the index
date from all inpatient and outpatient claims within
12 months prior to the index admission, there were
generally increases in the AICs and BICs.
Discussion
Several studies have been conducted to compare the
performance of the two most common risk adjustment
methods, the Charlson and the Elixhauser methods
[9,15,18,19]. This article adds to the literature by
applying the CMS-HCC risk adjustment to predict
mortality outcomes and comparing its performance
with the Charlson and Elixhauser methods. Our find-
ings suggest that the CMS-HCC method outperforms
the Charlson and Elixhauser methods in predicting the
risk of in-hospital and six-month mortality among all
Medicare beneficiaries with a hospital admission
including subgroups with a principal diagnosis of AMI,
CHF, DM, and stroke. Based on point estimates of c-
statistic, we also found that the Elixhauser method was
superior to the Charlson method in models including
individual diagnosis indicators to predict mortality.
This is consistent with the previous literature
[15,18,19].
There are several possible explanations for the super-
ior performance of the CMS-HCC method. First, the
CMS-HCC risk adjustment method captures more con-
ditions than the Charlson and Elixhauser methods. The
CMS-HCC aggregates 189 condition categories into 70
categories [3], while the Charlson identifies 19 comor-
bidities [1] and the Elixhauser identifies 30 comorbid-
ities [2]. Second, the CMS-HCC has more detailed
information on the severity of a condition relative to the
Elixhauser and Charlson methods. For example, under
the CMS-HCC method, a patient with diabetes can be
coded as HCC19 (diabetes without complications),
HCC18 (diabetes with ophthalmologic or unspecified
manifestation), HCC17 (diabetes with acute complica-
tions), HCC16 (diabetes with neurologic or other speci-
fied manifestation), or HCC15 (diabetes with renal
manifestation) [3] depending on the severity and com-
plications associated with his/her diabetes. On the other
hand, there are only two categories for diabetes under
both the Charlson method (diabetes, mild to moderate
vs. diabetes with chronic complications) [6] and the
Elixhauser method (diabetes, uncomplicated vs. diabetes,
complicated) [2]. Third, the CMS-HCC captures more
complications that result from the process of care rela-
tive to the Charlson and Elixhauser methods. The
Charlson and Elixhauser methods only include comor-
bidities and remove complications from the models
given that one of the main purposes of these risk adjust-
ment methods is to adjust for the baseline health status
differences across patients before they were admitted to
the hospital. Including complications due to the process
of hospital care could overestimate severity of patient
case mix among those who receive poorer inpatient
quality of care. The CMS-HCC tries to capture all con-
ditions associated with higher costs and hence includes
Table 1 C-statistic from logistic regression models predicting in-hospital mortality
a (Continued)
(0.715,
0.759)
(0.587,
0.639)
(0.582,
0.634)
(0.809,
0.848)
(0.631,
0.681)
(0.701,
0.748)
2) IPpre12mo+index 0.717 0.64** 0.632** 0.805 0.662** 0.709**
(0.697,
0.741)
(0.615,
0.664)
(0.611,
0.662)
(0.793,
0.833)
(0.643, 0.69) (0.691,
0.737)
3) IP+OPpre12mo +index 0.697 0.639** 0.646** 0.772 0.658** 0.7**
(0.677,
0.724)
(0.617,
0.667)
(0.625,
0.676)
(0.767,
0.806)
(0.643,
0.691)
(0.686,
0.732)
4) IP+OPpre12mo 0.643 0.635** 0.635** 0.686 0.657** 0.676**
(0.622,
0.673)
(0.613,
0.662)
(0.615,
0.667)
(0.686,
0.732)
(0.64, 0.689) (0.665,
0.712)
Note: **:The c-statistic is significantly different from the c-statistic of the CMS-HCC model at the 5% level.
NA: Models did not converge due to complete (or quasi-complete) separation.
a 95% confidence intervals of c-statistics are in parentheses.
b. Four analytic files were used to code risk adjusters: “IPindex” only included claims from the index hospitalization for each of the four disease samples.
“IPpre12mo+index” included all inpatient claims in the 12 months prior to the index hospitalization including the index admission date. “IP+OPpre12mo+index”
included all inpatient and outpatient claims in the 12 months prior to the index hospitalization including the index admission date. “IP+OPpre12mo” included all
inpatient and outpatient claims in the 12 months prior to the index hospitalization excluding the index admission date.
c. Patients with any hospital admission between January 1
st, 2006 and June 30
th, 2006.
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Page 6 of 10Table 2 C-statistic from logistic regression models predicting six-month mortality
a
Sample Analytic file used to code risk adjusters
b Summary score Condition indicators
CMS-HCC Charlson Elixhauser CMS-HCC Charlson Elixhauser
All patients
c (N = 170,342)
1) IPindex 0.799 0.728** 0.680** 0.827 0.743** 0.757**
(0.796, 0.802) (0.725, 0.731) (0.677, 0.684) (0.824, 0.830) (0.740, 0.746) (0.754, 0.760)
2) IPpre12mo+index 0.790 0.739** 0.7** 0.825 0.753** 0.766**
(0.787, 0.793) (0.736, 0.742) (0.696, 0.703) (0.823, 0.828) (0.749, 0.756) (0.763, 0.769)
3) IP+OPpre12mo +index 0.774 0.735** 0.719** 0.819 0.754** 0.777**
(0.771, 0.777) (0.732, 0.738) (0.716, 0.722) (0.816, 0.822) (0.751, 0.757) (0.774, 0.780)
4) IP+OPpre12mo 0.716 0.711** 0.696** 0.745 0.726** 0.739**
(0.712, 0.719) (0.717, 0.714) (0.692, 0.699) (0.742, 0.748) (0.722, 0.729) (0.736, 0.743)
DM (N = 2,339)
1) IPindex 0.736 0.706** 0.685** 0.796 0.721** 0.753**
(0.712, 0.763) (0.676, 0.734) (0.654, 0.712) (0.786, 0.832) (0.699, 0.753) (0.736, 0.787)
2) IPpre12mo+index 0.74 0.724** 0.7** 0.796 0.739** 0.758**
(0.719, 0.773) (0.701, 0.755) (0.679, 0.736) (0.795, 0.84) (0.723, 0.777) (0.749, 0.797)
3) IP+OPpre12mo +index 0.733 0.72** 0.699** NA NA 0.762
(0.712, 0.767) (0.697, 0.749) (0.678, 0.733) (0.752, 0.799)
4) IP+OPpre12mo 0.703 0.698** 0.682** NA 0.722** 0.737**
(0.681, 0.742) (0.676, 0.731) (0.66, 0.719) (0.708, 0.761) (0.729, 0.78)
Stroke (N = 9,828)
1) IPindex 0.79 0.667** 0.662** 0.842 0.682** 0.728**
(0.776, 0.799) (0.651, 0.679) (0.647, 0.675) (0.833, 0.853) (0.668, 0.695) (0.717, 0.742)
2) IPpre12mo+index 0.774 0.683** 0.684** 0.841 0.701** 0.736**
(0.76, 0.784) (0.67, 0.696) (0.672, 0.698) (0.832, 0.853) (0.691, 0.716) (0.725, 0.75)
3) IP+OPpre12mo +index 0.752 0.679** 0.693** 0.83 0.712** 0.739**
(0.739, 0.763) (0.665, 0.692) (0.682, 0.708) (0.821, 0.842) (0.699, 0.725) (0.729, 0.754)
4) IP+OPpre12mo 0.688 0.675** 0.679** 0.718 0.706** 0.709**
(0.677, 0.703) (0.662, 0.689) (0.668, 0.695) (0.712, 0.737) (0.693, 0.719) (0.701, 0.726)
AMI (N = 5,749)
1) IPindex 0.777 0.692** 0.678** 0.811 0.704** 0.749**
(0.763, 0.789) (0.677, 0.707) (0.661, 0.693) (0.801, 0.826) (0.69, 0.721) (0.736, 0.764)
2) IPpre12mo+index 0.776 0.71** 0.705** 0.814 0.719** 0.75**
(0.763, 0.789) (0.695, 0.725) (0.691, 0.721) (0.805, 0.83) (0.706, 0.736) (0.738, 0.767)
3) IP+OPpre12mo +index 0.77 0.713** 0.727** 0.813 0.725** 0.763**
(0.757, 0.783) (0.699, 0.729) (0.714, 0.742) (0.805, 0.829) (0.713, 0.743) (0.752, 0.78)
4) IP+OPpre12mo 0.72 0.707** 0.712** 0.741 0.717** 0.732**
(0.706, 0.737) (0.693, 0.723) (0.698, 0.728) (0.736, 0.764) (0.705, 0.735) (0.721, 0.751)
CHF(N = 11,287)
1) IPindex 0.685 0.653** 0.642** 0.719 0.669** 0.7**
(0.675, 0.697) (0.642, 0.665) (0.631, 0.654) (0.712, 0.733) (0.659, 0.681) (0.69, 0.712)
2) IPpre12mo+index 0.694 0.671** 0.668** 0.725 0.681** 0.709**
(0.685, 0.707) (0.661, 0.684) (0.658, 0.681) (0.719, 0.739) (0.673, 0.695) (0.701, 0.723)
3) IP+OPpre12mo +index 0.69 0.666** 0.671** 0.721 0.679** 0.702**
(0.682, 0.704) (0.656, 0.679) (0.662, 0.685) (0.715, 0.736) (0.671, 0.693) (0.695, 0.716)
4) IP+OPpre12mo 0.674 0.663** 0.664** 0.698 0.675** 0.688**
(0.665, 0.689) (0.654, 0.677) (0.655, 0.679) (0.694, 0.715) (0.667, 0.69) (0.682, 0.704)
Note: **: The c-statistic is significantly different from the c-statistic of CMS-HCC model at the 5% level;
NA: Models did not converge due to complete (or quasi-complete) separation.
a. 95% confidence intervals of c-statistics are in parentheses.
b. Four analytic files were used to code risk adjusters: “IPindex” only included claims from the index hospitalization for each of the four disease samples.
“IPpre12mo+index” included all inpatient claims in the 12 months prior to the index hospitalization including the index admission date. “IP+OPpre12mo+index”
included all inpatient and outpatient claims in the 12 months prior to the index hospitalization including the index admission date. “IP+OPpre12mo “ included all
inpatient and outpatient claims in the 12 months prior to the index hospitalization excluding the index admission date.
c. Patients with any hospital admission between January 1
st, 2006 and June 30
th, 2006.
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dict Medicare expenditures. For example, pneumonia is
included in CMS-HCC (as HCC111 and HCC112) but
not in the Charlson and Elixhauser comorbidity lists
because it is not distinguishable from a complication
arising in the hospital [2]. Some diagnoses (e.g. myocar-
dial infarction) included in the Charlson index might be
due to complications of procedures (e.g. lumbar spine
surgery) [5]. Therefore, the Charlson method includes
them only if the condition occurred prior to the index
hospitalization [5,6].
Inpatient mortality rates are often used to measure
quality of care inside hospitals [20]. Risk adjustment is
needed to ensure a fair comparison across hospitals by
adjusting for patients’ baseline clinical risk prior to hos-
pital admission (e.g. comorbidities). However, if a risk
adjustment method not only adjusts for pre-admission
conditions, but also takes into account complications
due to poor quality of inpatient care, it could potentially
lead to a biased conclusion. The influence of complica-
tions due to the inpatient process of care can be elimi-
nated by coding risk adjusters based on the pre-index
date claims (i.e. the fourth analytical file in our study).
However, as our results highlighted, removing the index
date claim resulted in poorer predictions for both
in-hospital and six-month mortality across all three
methods. In-hospital mortality models had larger drops
in c-statistic values than six-month mortality. The rea-
son may be that in-hospital mortality is highly corre-
lated with the conditions and complications during the
inpatient stay. The CMS-HCC models had a larger drop
in performance than the other two risk adjustment
methods. In spite of this, the CMS-HCC still performed
as well or better than the other two methods when we
removed the influence of concurrent complications aris-
ing during the hospitalization by coding risk adjusters
based only on the pre-index date claims.
In addition, the predictive power of the CMS-HCC
models predicting in-hospital mortality decreased when
additional diagnostic information from inpatient and out-
patient claims in the 12-month prior to admission was
included. This is in contrast to the Charlson and Elixhau-
ser models whose performance in predicting in-hospital
mortality increased with the inclusion of additional
Table 3 Change in c-statistics upon exclusion of claims occurring on the index admission date
a
Summary score Indicators
Outcome Sample CMS-HCC Charlson Elixhauser CMS-HCC Charlson Elixhauser
In-hospital All patients
b -0.133** -0.017** -0.027** -0.196** -0.021** -0.06**
(N = 170,342) (-0.139,-0.127) (-0.019,-0.014) (-0.03, -0.024) (-0.203, -0.189) (-0.025, -0.017) (-0.065, -0.054)
DM -0.082** 0.016 -0.010 NA NA NA
(N = 2,339) (-0.113, -0.035) (-0.023, 0.029) (-0.045, 0.008)
Stroke -0.128** -0.001 -0.013** NA -0.008 -0.042
(N = 9,828) (-0.147, -0.1) (-0.006, 0.002) (-0.02, -0.005) (-0.017, 0.001) (-0.055, -0.02)
AMI -0.081** -0.001 -0.011** NA 0.001 -0.038
(N = 5,749) (-0.095, -0.063) (-0.005, 0.003) (-0.017, -0.005) (-0.009, 0.009) (-0.053, -0.018)
CHF -0.054** -0.004 -0.011** -0.086** -0.001 -0.024**
(N = 11,287) (-0.066, -0.041) (-0.011, 0.002) (-0.018, -0.002) (-0.096, -0.06) (-0.012, 0.007) (-0.035, -0.009)
Six-month All patients
b -0.058** -0.024** -0.023** -0.074** -0.028** -0.038**
(N = 170,342) (-0.06, -0.056) (-0.026, -0.022) (-0.025, -0.022) (-0.076, -0.071) (-0.03, -0.026) (-0.04,-0.036)
DM -0.030** -0.022** -0.017** -0.029** NA -0.025**
(N = 2,339) (-0.038, -0.018) (-0.031, -0.008) (-0.024, -0.008) (-0.044, -0.012) (-0.038, -0.007)
Stroke -0.064** -0.004** -0.014** -0.112** -0.006** -0.030**
(N = 9,828) (-0.07, -0.053) (-0.006, -0.001) (-0.017, -0.01) (-0.119, -0.096) (-0.01, -0.002) (-0.035, -0.022)
AMI -0.050** -0.006** -0.015** -0.072** -0.008** -0.031**
(N = 5,749) (-0.057, -0.041) (-0.009, -0.002) (-0.02, -0.01) (-0.08, -0.056) (-0.012, -0.003) (-0.038, -0.022)
CHF -0.016** -0.003 -0.007** -0.023** -0.004 -0.014**
(N = 11,287) (-0.02, -0.012) (-0.005, 0) (-0.01, -0.003) (-0.026, -0.016) (-0.007, 0) (-0.017, -0.007)
Note: **: The c-statistic of the model “IP+OPpre12mo+index” (included all inpatient and outpatient claims in the 12 months prior to the index hospitalization
including the index admission date) is statistically significant different from the model “IP+OPpre12mo “ (included all inpatient and outpatient claims in the 12
months prior to the index hospitalization excluding the index admission date) at the 5% level;
NA: Models did not converge due to complete (or quasi-complete) separation.
a Change in c-statistics upon exclusion of claims occurring on the index admission date was estimated by comparing c-statistic of the model “IP+OPpre12mo
+index” (included all inpatient and outpatient claims in the 12 months prior to the index hospitalization including the index admission date) and the c-statistic of
the model “IP+OPpre12mo “ (included all inpatient and outpatient claims in the 12 months prior to the index hospitalization excluding the index admission
date); 95% confidence intervals of measures are in parentheses.
b Patients with any hospital admission between January 1
st, 2006 and June 30
th, 2006.
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Page 8 of 10information. This difference may occur due to the fact
that the clinical complications during the index hospitali-
zation included only in the CMS-HCC model play an
important role in its predictive performance for in-hospi-
tal mortality and adding prior diagnostic information
dilutes its prediction power (Table 1 and Table 3).
The Charlson and Elixhauser methods were originally
designed to serve as risk adjusters using only inpatient
or hospital discharge data. Health services researchers
have been increasingly using both inpatient and outpati-
ent data for coding these two risk adjusters given the
wide availability of longitudinal administrative claims
datasets. However, these data also make it possible to
exclude diagnoses codes related to complications due to
inpatient processes of care by only including diagnoses
from inpatient and outpatient claims identified before
the index hospitalization date (i.e. exclude index hospi-
talization claim). In this case, our results indicate that
the CMS-HCC is more favorable than the other two
methods because it captures more comprehensive diag-
nosis information than the Charlson and Elixhauser
methods and complications due to inpatient processes
of care are not an issue. However, one should be careful
when using CMS-HCC without removing diagnoses
from index hospitalization particularly in studies evalu-
ating inpatient processes of care.
There are several limitations of our study that should
be addressed. First, some of our models using individual
diagnosis indicators failed to converge. This may be due
to our small sample sizes for some conditions which
limited our ability to conduct a full comparison across
all conditions and analytic files for the individual diag-
nosis indicator models across the three methods. How-
ever, all models converged for our primary sample of all
patients with hospital admissions and the results were
consistent with those from the models that converged in
the disease-specific samples. Second, we limited our
assessment of the outcomes to in-hospital and six-
month mortality. Model performance may be different
when examining a longer time horizon for mortality as
well as for other health outcomes. Finally, our evaluation
of the three risk-adjustment methods was conducted
using samples of Medicare beneficiaries. Since the CMS-
HCC risk score was originally developed and calibrated
using data on Medicare beneficiaries whereas Charlson
and Elixhauser methods were not, it is possible that our
s t u d yr e s u l t sw e r em o r ef a v o r a b l ef o rt h eC M S - H C C .
H o w e v e r ,o n em i g h ta r g u et h a tt h eC M S - H C Cm e t h o d
was developed to predict Medicare expenditures and not
mortality unlike the other two methods. Nevertheless,
future evaluations of these risk adjustment methods in
other patient populations are needed.
Conclusion
The CMS-HCC risk adjustment models demonstrated
better performance relative to the Charlson and Elixhau-
ser models in predicting in-hospital and six-month mor-
tality. The CMS-HCC model is preferred over the
Charlson and Elixhauser methods if patient diagnoses
prior to the index hospitalization are available and can
be used to code these risk adjusters. However, it should
be used cautiously in studies focused on evaluating inpa-
tient processes of care when complications due to pro-
cess of care cannot be identified and excluded based on
available data.
The data used for the study is not openly available.
This study is approved by University of Pennsylvania
Institutional Review Board.
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